KNTPF
Price
$0.33
Change
+$0.05 (+17.86%)
Updated
Jan 14 closing price
Capitalization
137.04M
Intraday BUY SELL Signals
UNCY
Price
$6.25
Change
-$0.36 (-5.45%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
142.06M
Intraday BUY SELL Signals
Interact to see
Advertisement

KNTPF vs UNCY

Header iconKNTPF vs UNCY Comparison
Open Charts KNTPF vs UNCYBanner chart's image
KINTOR PHARMACEUTICAL
Price$0.33
Change+$0.05 (+17.86%)
Volume$500
Capitalization137.04M
Unicycive Therapeutics
Price$6.25
Change-$0.36 (-5.45%)
Volume$4.81K
Capitalization142.06M
KNTPF vs UNCY Comparison Chart in %
KNTPF
Daily Signal:
Gain/Loss:
UNCY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KNTPF vs. UNCY commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNTPF is a Hold and UNCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (KNTPF: $0.33 vs. UNCY: $6.61)
Brand notoriety: KNTPF and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNTPF: 88% vs. UNCY: 215%
Market capitalization -- KNTPF: $137.04M vs. UNCY: $142.06M
KNTPF [@Biotechnology] is valued at $137.04M. UNCY’s [@Biotechnology] market capitalization is $142.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNTPF’s FA Score shows that 0 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • KNTPF’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, both KNTPF and UNCY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNTPF’s TA Score shows that 4 TA indicator(s) are bullish while UNCY’s TA Score has 6 bullish TA indicator(s).

  • KNTPF’s TA Score: 4 bullish, 4 bearish.
  • UNCY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, UNCY is a better buy in the short-term than KNTPF.

Price Growth

KNTPF (@Biotechnology) experienced а +19.85% price change this week, while UNCY (@Biotechnology) price change was +9.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UNCY($142M) and KNTPF($137M) have the same market capitalization . KNTPF YTD gains are higher at: 54.213 vs. UNCY (14.558).
KNTPFUNCYKNTPF / UNCY
Capitalization137M142M96%
EBITDAN/A-32.79M-
Gain YTD54.21314.558372%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A42.7M-
Total DebtN/A505K-
TECHNICAL ANALYSIS
Technical Analysis
KNTPFUNCY
RSI
ODDS (%)
Bearish Trend 2 days ago
56%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
34%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
28%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KNTPF
Daily Signal:
Gain/Loss:
UNCY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMTDF32.25N/A
N/A
Sumitomo Mitsui Trust Group, Inc.
MTLRF1.70N/A
N/A
Metalore Resources Limited
FITGF0.54N/A
N/A
Foxconn Interconnect Technology Ltd.
ADLRF15.43N/A
N/A
ALARIS EQUITY PARTNERS INCOME TR
SACQF10.06N/A
N/A
Spree Acquisition Corp. 1 Limited

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and MLEC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and MLEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
+19.85%
MLEC - KNTPF
27%
Poorly correlated
-28.11%
KNSA - KNTPF
20%
Poorly correlated
+2.49%
UNCY - KNTPF
20%
Poorly correlated
+9.62%
RLFTY - KNTPF
20%
Poorly correlated
N/A
BCTX - KNTPF
9%
Poorly correlated
-55.49%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with INDP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+9.62%
INDP - UNCY
51%
Loosely correlated
+1.31%
CDTX - UNCY
44%
Loosely correlated
N/A
ICU - UNCY
41%
Loosely correlated
-2.79%
IBO - UNCY
37%
Loosely correlated
+0.25%
UTHR - UNCY
32%
Poorly correlated
-0.24%
More